| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | COMTD1 EZH1 EZH2 PRDM9 EHMT2 KMT2A PRMT7 NNMT NSUN6 INMT SETBP1 PCIF1 | 5.90e-06 | 172 | 280 | 12 | GO:0008757 |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 1.71e-05 | 105 | 280 | 9 | GO:0008170 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN12 F2 TTN SVEP1 ITPR1 DUOX1 HMCN2 EFCAB12 PLSCR2 CAPS2 HSPG2 NID2 FBLN7 EFCAB6 CANX PCDHB10 PCDHB2 ADAMTS13 PCDHB18P THBD HMCN1 MEGF8 SYT8 LTBP2 FBN3 CRB2 | 2.15e-05 | 749 | 280 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.25e-05 | 44 | 280 | 6 | GO:0140938 | |
| GeneOntologyMolecularFunction | methyltransferase activity | COMTD1 EZH1 EZH2 PRDM9 EHMT2 KMT2A PRMT7 NNMT NSUN6 INMT SETBP1 PCIF1 | 4.99e-05 | 213 | 280 | 12 | GO:0008168 |
| GeneOntologyMolecularFunction | histone H3K27 methyltransferase activity | 5.29e-05 | 6 | 280 | 3 | GO:0046976 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 6.11e-05 | 71 | 280 | 7 | GO:0042054 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | COMTD1 EZH1 EZH2 PRDM9 EHMT2 KMT2A PRMT7 NNMT NSUN6 INMT SETBP1 PCIF1 | 8.09e-05 | 224 | 280 | 12 | GO:0016741 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.34e-04 | 188 | 280 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.81e-04 | 68 | 280 | 6 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 4.12e-04 | 69 | 280 | 6 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone H3K27 trimethyltransferase activity | 5.82e-04 | 3 | 280 | 2 | GO:0140951 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 6.23e-04 | 103 | 280 | 7 | GO:0008276 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 8.19e-04 | 140 | 280 | 8 | GO:0001221 | |
| GeneOntologyMolecularFunction | collagen binding | 9.70e-04 | 81 | 280 | 6 | GO:0005518 | |
| GeneOntologyBiologicalProcess | animal organ regeneration | 1.07e-05 | 79 | 276 | 8 | GO:0031100 | |
| GeneOntologyBiologicalProcess | response to tetrachloromethane | 2.32e-05 | 5 | 276 | 3 | GO:1904772 | |
| GeneOntologyBiologicalProcess | positive regulation of blood coagulation | 5.29e-05 | 31 | 276 | 5 | GO:0030194 | |
| GeneOntologyBiologicalProcess | positive regulation of hemostasis | 5.29e-05 | 31 | 276 | 5 | GO:1900048 | |
| GeneOntologyBiologicalProcess | platelet activation | 5.50e-05 | 158 | 276 | 10 | GO:0030168 | |
| GeneOntologyBiologicalProcess | positive regulation of coagulation | 8.38e-05 | 34 | 276 | 5 | GO:0050820 | |
| GeneOntologyBiologicalProcess | facultative heterochromatin formation | 9.09e-05 | 55 | 276 | 6 | GO:0140718 | |
| GeneOntologyCellularComponent | extracellular matrix | F2 SSPOP SVEP1 HMCN2 SPON2 NAV2 PLSCR2 CCN3 VWC2 HSPG2 NID2 FBLN7 MXRA5 VWF OLFML2B COL5A3 REG1B ADAMTS13 FCN3 HMCN1 LPA LTBP2 FBN3 ADAMTSL2 | 1.32e-05 | 656 | 286 | 24 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | F2 SSPOP SVEP1 HMCN2 SPON2 NAV2 PLSCR2 CCN3 VWC2 HSPG2 NID2 FBLN7 MXRA5 VWF OLFML2B COL5A3 REG1B ADAMTS13 FCN3 HMCN1 LPA LTBP2 FBN3 ADAMTSL2 | 1.39e-05 | 658 | 286 | 24 | GO:0030312 |
| GeneOntologyCellularComponent | subapical complex | 2.48e-05 | 5 | 286 | 3 | GO:0035003 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 5.42e-04 | 28 | 286 | 4 | GO:0016327 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 5.68e-04 | 75 | 286 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | PcG protein complex | 7.11e-04 | 52 | 286 | 5 | GO:0031519 | |
| GeneOntologyCellularComponent | methyltransferase complex | 7.17e-04 | 108 | 286 | 7 | GO:0034708 | |
| Domain | Sushi_SCR_CCP_dom | 1.26e-07 | 57 | 272 | 9 | IPR000436 | |
| Domain | Sushi | 7.89e-07 | 52 | 272 | 8 | PF00084 | |
| Domain | Ig_I-set | AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 ADGRF5 MERTK HSPG2 MXRA5 ROR1 HMCN1 WFIKKN1 | 7.90e-07 | 190 | 272 | 14 | IPR013098 |
| Domain | I-set | AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 ADGRF5 MERTK HSPG2 MXRA5 ROR1 HMCN1 WFIKKN1 | 7.90e-07 | 190 | 272 | 14 | PF07679 |
| Domain | CCP | 1.06e-06 | 54 | 272 | 8 | SM00032 | |
| Domain | SUSHI | 1.42e-06 | 56 | 272 | 8 | PS50923 | |
| Domain | EGF_Ca-bd_CS | 1.50e-06 | 97 | 272 | 10 | IPR018097 | |
| Domain | EGF_CA | SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 LTBP2 FBN3 CRB2 | 1.72e-06 | 122 | 272 | 11 | SM00179 |
| Domain | EGF_CA | 1.81e-06 | 99 | 272 | 10 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.99e-06 | 100 | 272 | 10 | PS00010 | |
| Domain | EGF-like_Ca-bd_dom | SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 LTBP2 FBN3 CRB2 | 2.02e-06 | 124 | 272 | 11 | IPR001881 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.39e-06 | 106 | 272 | 10 | IPR000152 | |
| Domain | EGF_CA | 4.46e-06 | 86 | 272 | 9 | PF07645 | |
| Domain | IGc2 | NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 HSPG2 MXRA5 ROR1 HMCN1 WFIKKN1 IL6R | 9.52e-06 | 235 | 272 | 14 | SM00408 |
| Domain | Ig_sub2 | NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 HSPG2 MXRA5 ROR1 HMCN1 WFIKKN1 IL6R | 9.52e-06 | 235 | 272 | 14 | IPR003598 |
| Domain | NIDOGEN_G2 | 1.21e-05 | 4 | 272 | 3 | PS50993 | |
| Domain | G2_nidogen/fibulin_G2F | 1.21e-05 | 4 | 272 | 3 | IPR006605 | |
| Domain | G2F | 1.21e-05 | 4 | 272 | 3 | PF07474 | |
| Domain | GFP | 1.21e-05 | 4 | 272 | 3 | IPR009017 | |
| Domain | IG | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 MERTK HSPG2 ISLR2 MXRA5 ROR1 HHLA2 HMCN1 WFIKKN1 IL6R | 1.43e-05 | 421 | 272 | 19 | SM00409 |
| Domain | Ig_sub | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 MERTK HSPG2 ISLR2 MXRA5 ROR1 HHLA2 HMCN1 WFIKKN1 IL6R | 1.43e-05 | 421 | 272 | 19 | IPR003599 |
| Domain | TSP_1 | 3.55e-05 | 63 | 272 | 7 | PF00090 | |
| Domain | EGF_3 | SSPOP SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 4.30e-05 | 235 | 272 | 13 | PS50026 |
| Domain | TSP1_rpt | 4.35e-05 | 65 | 272 | 7 | IPR000884 | |
| Domain | TSP1 | 4.35e-05 | 65 | 272 | 7 | PS50092 | |
| Domain | TSP1 | 4.35e-05 | 65 | 272 | 7 | SM00209 | |
| Domain | Tesmin/TSO1-like_CXC | 5.91e-05 | 6 | 272 | 3 | IPR033467 | |
| Domain | CXC | 5.91e-05 | 6 | 272 | 3 | SM01114 | |
| Domain | ConA-like_dom | TRIML1 SVEP1 PAPPA2 HSPG2 CANX TSPEAR COL5A3 MAMDC4 PAPPA RFPL3 RFPL2 CRB2 | 9.26e-05 | 219 | 272 | 12 | IPR013320 |
| Domain | EGF | 9.63e-05 | 126 | 272 | 9 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 9.87e-05 | 156 | 272 | 10 | IPR009030 | |
| Domain | IG_LIKE | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 MERTK HSPG2 ISLR2 MXRA5 ROR1 HHLA2 HMCN1 WFIKKN1 IL6R | 1.13e-04 | 491 | 272 | 19 | PS50835 |
| Domain | CUB | 1.17e-04 | 53 | 272 | 6 | PS01180 | |
| Domain | EGF_2 | SSPOP SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 1.45e-04 | 265 | 272 | 13 | PS01186 |
| Domain | Ig-like_dom | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 VSIG10L ADGRF5 MERTK HSPG2 ISLR2 MXRA5 ROR1 HHLA2 HMCN1 WFIKKN1 IL6R | 1.55e-04 | 503 | 272 | 19 | IPR007110 |
| Domain | CUB_dom | 1.76e-04 | 57 | 272 | 6 | IPR000859 | |
| Domain | L27_2 | 2.11e-04 | 2 | 272 | 2 | PF09045 | |
| Domain | DUF4594 | 2.11e-04 | 2 | 272 | 2 | PF15266 | |
| Domain | DUF4594 | 2.11e-04 | 2 | 272 | 2 | IPR029336 | |
| Domain | L27_2 | 2.11e-04 | 2 | 272 | 2 | IPR015132 | |
| Domain | Peptidase_M43 | 2.11e-04 | 2 | 272 | 2 | PF05572 | |
| Domain | EZH1/EZH2 | 2.11e-04 | 2 | 272 | 2 | IPR021654 | |
| Domain | Peptidase_M43 | 2.11e-04 | 2 | 272 | 2 | IPR008754 | |
| Domain | CXC | 2.11e-04 | 2 | 272 | 2 | PS51633 | |
| Domain | EZH2_WD-Binding | 2.11e-04 | 2 | 272 | 2 | PF11616 | |
| Domain | CXC_dom | 2.11e-04 | 2 | 272 | 2 | IPR026489 | |
| Domain | DUF1220 | 2.40e-04 | 9 | 272 | 3 | SM01148 | |
| Domain | Ig-like_fold | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 FNDC7 HMCN2 NFATC2 VSIG10L ADGRF5 MERTK PAPPA2 HSPG2 ISLR2 MXRA5 ROR1 IFNAR2 HHLA2 HMCN1 WFIKKN1 IL6R | 2.82e-04 | 706 | 272 | 23 | IPR013783 |
| Domain | - | SIGLEC9 AXL NFASC TTN CADM2 IGSF10 TYRO3 FNDC7 NFATC2 VSIG10L ADGRF5 MERTK PAPPA2 HSPG2 ISLR2 MXRA5 ROR1 IFNAR2 HHLA2 HMCN1 WFIKKN1 IL6R | 2.98e-04 | 663 | 272 | 22 | 2.60.40.10 |
| Domain | EGF-like_dom | SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 3.06e-04 | 249 | 272 | 12 | IPR000742 |
| Domain | SET | 3.08e-04 | 41 | 272 | 5 | PF00856 | |
| Domain | EGF_1 | SSPOP SVEP1 HMCN2 HSPG2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 3.79e-04 | 255 | 272 | 12 | PS00022 |
| Domain | DUF1220 | 4.62e-04 | 11 | 272 | 3 | PF06758 | |
| Domain | NBPF_dom | 4.62e-04 | 11 | 272 | 3 | IPR010630 | |
| Domain | NBPF | 4.62e-04 | 11 | 272 | 3 | PS51316 | |
| Domain | GFP-like | 4.62e-04 | 11 | 272 | 3 | IPR023413 | |
| Domain | - | 4.62e-04 | 11 | 272 | 3 | 2.40.155.10 | |
| Domain | EGF-like_CS | SVEP1 HMCN2 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 4.67e-04 | 261 | 272 | 12 | IPR013032 |
| Domain | - | 4.77e-04 | 95 | 272 | 7 | 2.60.120.200 | |
| Domain | ig | 4.86e-04 | 190 | 272 | 10 | PF00047 | |
| Domain | Immunoglobulin | 4.86e-04 | 190 | 272 | 10 | IPR013151 | |
| Domain | cEGF | 5.11e-04 | 26 | 272 | 4 | PF12662 | |
| Domain | cEGF | 5.11e-04 | 26 | 272 | 4 | IPR026823 | |
| Domain | SET | 5.31e-04 | 46 | 272 | 5 | SM00317 | |
| Domain | HARE-HTH | 6.28e-04 | 3 | 272 | 2 | PF05066 | |
| Domain | ASXH | 6.28e-04 | 3 | 272 | 2 | PF13919 | |
| Domain | PHD_3 | 6.28e-04 | 3 | 272 | 2 | PF13922 | |
| Domain | NNMT/PNMT/TEMT_CS | 6.28e-04 | 3 | 272 | 2 | IPR025820 | |
| Domain | NNMT_TEMT_trans | 6.28e-04 | 3 | 272 | 2 | IPR000940 | |
| Domain | ASXH | 6.28e-04 | 3 | 272 | 2 | IPR028020 | |
| Domain | NNMT_PNMT_TEMT | 6.28e-04 | 3 | 272 | 2 | PS01100 | |
| Domain | ASX/ASX-like | 6.28e-04 | 3 | 272 | 2 | IPR024811 | |
| Domain | Myelin_TF | 6.28e-04 | 3 | 272 | 2 | IPR013681 | |
| Domain | ASX-like_PHD | 6.28e-04 | 3 | 272 | 2 | IPR026905 | |
| Domain | Myxo_disulph_rpt | 6.28e-04 | 3 | 272 | 2 | IPR011936 | |
| Domain | SAM_MT_NNMT_PNMT_TEMT | 6.28e-04 | 3 | 272 | 2 | PS51681 | |
| Domain | NNMT_PNMT_TEMT | 6.28e-04 | 3 | 272 | 2 | PF01234 | |
| Domain | MYT1 | 6.28e-04 | 3 | 272 | 2 | PF08474 | |
| Domain | G2F | 6.28e-04 | 3 | 272 | 2 | SM00682 | |
| Domain | HB1/Asxl_HTH | 6.28e-04 | 3 | 272 | 2 | IPR007759 | |
| Domain | EGF | SVEP1 HSPG2 NID2 FBLN7 THBD HMCN1 MEGF8 TENM1 LTBP2 FBN3 CRB2 | 6.89e-04 | 235 | 272 | 11 | SM00181 |
| Domain | CUB | 7.13e-04 | 49 | 272 | 5 | PF00431 | |
| Domain | CUB | 7.83e-04 | 50 | 272 | 5 | SM00042 | |
| Domain | SET_dom | 7.83e-04 | 50 | 272 | 5 | IPR001214 | |
| Domain | SET | 7.83e-04 | 50 | 272 | 5 | PS50280 | |
| Domain | - | 9.38e-04 | 52 | 272 | 5 | 2.60.120.290 | |
| Domain | Kringle-like | 1.15e-03 | 32 | 272 | 4 | IPR013806 | |
| Domain | LamGL | 1.24e-03 | 4 | 272 | 2 | SM00560 | |
| Domain | LamG-like | 1.24e-03 | 4 | 272 | 2 | IPR006558 | |
| Domain | KR | 1.79e-03 | 17 | 272 | 3 | SM00130 | |
| Domain | Kringle | 1.79e-03 | 17 | 272 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 1.79e-03 | 17 | 272 | 3 | PS50070 | |
| Domain | Kringle_CS | 1.79e-03 | 17 | 272 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 1.79e-03 | 17 | 272 | 3 | PS00021 | |
| Domain | Kringle | 1.79e-03 | 17 | 272 | 3 | PF00051 | |
| Domain | VWFC_1 | 1.80e-03 | 36 | 272 | 4 | PS01208 | |
| Domain | RDM_domain_RFPL | 2.05e-03 | 5 | 272 | 2 | IPR022723 | |
| Domain | RDM | 2.05e-03 | 5 | 272 | 2 | PF11002 | |
| Domain | YD | 2.05e-03 | 5 | 272 | 2 | IPR006530 | |
| Domain | CTCK_1 | 2.12e-03 | 18 | 272 | 3 | PS01185 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 EPPK1 ANKRD37 SREBF1 MED14 C15orf39 ATG2A MDFI EDC4 COMTD1 REXO1 TNRC18 NAV2 LRRC56 CAMSAP1 LRRC8E SEMA4F DPH2 HSPG2 RHBDF1 SH3RF1 ZNF628 KHNYN LRRK1 REV3L ATP13A2 DENND1A NBPF1 IGF2R MAP1S MEGF8 INF2 ZNF335 DUSP16 TMEM268 TNKS1BP1 SNAPC4 MBD5 ZNF839 ESPL1 SYMPK | 1.70e-15 | 1105 | 292 | 41 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MED14 EZH2 REXO1 PASK SVIL KMT2A TAF6 MN1 HOMEZ KIF23 HDAC6 IQCN ARHGAP39 VIRMA SMTN TUBGCP6 GTF3C1 MAP1S ZNF335 TNKS1BP1 SNAPC4 ESPL1 CCDC9 SYMPK HDLBP | 1.20e-08 | 774 | 292 | 25 | 15302935 |
| Pubmed | 1.62e-08 | 21 | 292 | 6 | 16079250 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | BCORL1 PIDD1 NFASC CSMD2 SSPOP QRICH2 IGSF10 ALDH16A1 BOD1L1 BANK1 FBXO34 SEMA4F ZNF703 VWC2 TICRR MXRA5 CANX ROR1 REV3L GTF3C1 DUSP16 PCIF1 FBN3 SYMPK | 1.99e-08 | 736 | 292 | 24 | 29676528 |
| Pubmed | ABCA2 NFASC ATG2A PASK MTUS1 SEMA5B TECPR2 NAV2 HOMEZ ISLR2 RALGDS RELCH LRRK1 DIS3 TUBGCP6 SETBP1 TNKS1BP1 DIXDC1 ESPL1 NBR1 | 2.90e-08 | 529 | 292 | 20 | 14621295 | |
| Pubmed | The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity. | 7.21e-08 | 6 | 292 | 4 | 27034374 | |
| Pubmed | 3.07e-07 | 175 | 292 | 11 | 28071719 | ||
| Pubmed | High incidence of distal vaginal atresia in mice lacking Tyro3 RTK subfamily. | 5.86e-07 | 3 | 292 | 3 | 18393392 | |
| Pubmed | The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis. | 5.86e-07 | 3 | 292 | 3 | 17488688 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 30335822 | ||
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 17442946 | ||
| Pubmed | TAM receptor knockout mice are susceptible to retinal autoimmune induction. | 5.86e-07 | 3 | 292 | 3 | 21467176 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 25881761 | ||
| Pubmed | Transcriptome analysis of neural progenitor cells by a genetic dual reporter strategy. | 5.86e-07 | 3 | 292 | 3 | 21805534 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 31451482 | ||
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 25878564 | ||
| Pubmed | Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. | 5.86e-07 | 3 | 292 | 3 | 11452127 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 23071254 | ||
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 20637106 | ||
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 37537628 | ||
| Pubmed | Systemic autoimmunity in TAM triple knockout mice causes inflammatory brain damage and cell death. | 5.86e-07 | 3 | 292 | 3 | 23840307 | |
| Pubmed | Functions of TAM RTKs in regulating spermatogenesis and male fertility in mice. | 5.86e-07 | 3 | 292 | 3 | 19602523 | |
| Pubmed | Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. | 5.86e-07 | 3 | 292 | 3 | 10227296 | |
| Pubmed | TAM Receptors Are Not Required for Zika Virus Infection in Mice. | 5.86e-07 | 3 | 292 | 3 | 28423319 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 26523970 | ||
| Pubmed | TAM receptors support neural stem cell survival, proliferation and neuronal differentiation. | 5.86e-07 | 3 | 292 | 3 | 25514676 | |
| Pubmed | New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. | 5.86e-07 | 3 | 292 | 3 | 32051695 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 30541554 | ||
| Pubmed | AP-2α-Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis. | 5.86e-07 | 3 | 292 | 3 | 34210752 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 25074926 | ||
| Pubmed | TAM receptors and their ligand-mediated activation: Role in atherosclerosis. | 5.86e-07 | 3 | 292 | 3 | 33234243 | |
| Pubmed | Post-translational modifications of the ligands: Requirement for TAM receptor activation. | 5.86e-07 | 3 | 292 | 3 | 33234244 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 33234241 | ||
| Pubmed | Immunological role of TAM receptors in the cancer microenvironment. | 5.86e-07 | 3 | 292 | 3 | 33234245 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 18620092 | ||
| Pubmed | TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. | 5.86e-07 | 3 | 292 | 3 | 30765874 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 21192804 | ||
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 20483720 | ||
| Pubmed | TAM receptors are dispensable in the phagocytosis and killing of bacteria. | 5.86e-07 | 3 | 292 | 3 | 19625016 | |
| Pubmed | Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. | 5.86e-07 | 3 | 292 | 3 | 16751775 | |
| Pubmed | TAM receptors in apoptotic cell clearance, autoimmunity, and cancer. | 5.86e-07 | 3 | 292 | 3 | 23662598 | |
| Pubmed | 5.86e-07 | 3 | 292 | 3 | 23799121 | ||
| Pubmed | Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. | 5.86e-07 | 3 | 292 | 3 | 15733062 | |
| Pubmed | Tyro3 family-mediated cell entry of Ebola and Marburg viruses. | 5.86e-07 | 3 | 292 | 3 | 17005688 | |
| Pubmed | Hemostatic gene polymorphisms in young Sardinian with non-fatal acute myocardial infarction. | 9.82e-07 | 10 | 292 | 4 | 20036902 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 9.82e-07 | 10 | 292 | 4 | 22973535 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ASXL1 BCORL1 EZH1 EZH2 MTUS1 EHMT2 GALNT8 PPP1R3F KMT2A BOD1L1 KNL1 ZNF703 E2F1 PHC1 CTBP2 ASXL2 MBD5 | 1.21e-06 | 495 | 292 | 17 | 27705803 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MPDZ EDC4 DDX3X RUSC2 MYLK3 MTUS1 SVIL NAV2 KMT2A BOD1L1 KIF5C GNAS CAMSAP1 KIF23 SH3RF1 DBNL PLEKHG2 VIRMA DENND1A MEGF8 DCP1B TNKS1BP1 PATJ | 1.29e-06 | 861 | 292 | 23 | 36931259 |
| Pubmed | ABCA2 NBPF12 APC2 MED14 CSMD3 UBE2E1 NBPF8 CANX COL5A3 NBPF11 MINDY2 NBPF1 NBPF9 SETBP1 NBPF10 TENM1 PGM2 | 1.97e-06 | 513 | 292 | 17 | 25798074 | |
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 15650770 | ||
| Pubmed | Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target. | 2.33e-06 | 4 | 292 | 3 | 33532004 | |
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 21384080 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 30619243 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 36007682 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 27801848 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 16365397 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 18159085 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 12768229 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 20546121 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 8939948 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 8621659 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 25194421 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 20363878 | ||
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 28184013 | ||
| Pubmed | Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis. | 2.33e-06 | 4 | 292 | 3 | 20664904 | |
| Pubmed | 2.33e-06 | 4 | 292 | 3 | 31655933 | ||
| Pubmed | TAM Kinases Promote Necroptosis by Regulating Oligomerization of MLKL. | 2.33e-06 | 4 | 292 | 3 | 31230815 | |
| Pubmed | SVEP1 DDX3X MERTK CAMSAP1 EPN1 KNL1 PAPPA2 HSPG2 NID2 VWF CANX SMURF1 DCP1B UBE2D4 PAPPA CTBP2 ASXL2 HDLBP | 3.20e-06 | 591 | 292 | 18 | 15231748 | |
| Pubmed | TAM receptors are pleiotropic inhibitors of the innate immune response. | 3.28e-06 | 13 | 292 | 4 | 18083102 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | ARRDC1 AXL C1RL F2 SPON2 GNAS PTTG1IP PAPPA2 HSPG2 NID2 SELENOP CD177 CANX REG1B CR1 ABHD14B FETUB IGF2R HMCN1 MEGF8 TMPRSS2 LTBP2 PATJ PGM2 CRB2 | 4.76e-06 | 1070 | 292 | 25 | 23533145 |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ZBTB20 USP9X PLK5 MDM2 SVEP1 ITPR1 SHROOM4 MTUS1 NFATC2 NAV2 GNAS VWF CR1 ZNF335 TENM1 PALM3 GALNT4 | 5.20e-06 | 552 | 292 | 17 | 10737800 |
| Pubmed | 5.79e-06 | 5 | 292 | 3 | 24978606 | ||
| Pubmed | 5.79e-06 | 5 | 292 | 3 | 22043818 | ||
| Pubmed | 5.79e-06 | 5 | 292 | 3 | 23259948 | ||
| Pubmed | 5.79e-06 | 5 | 292 | 3 | 18188450 | ||
| Pubmed | Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. | 5.79e-06 | 5 | 292 | 3 | 25265470 | |
| Pubmed | 5.79e-06 | 5 | 292 | 3 | 20348395 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 7.14e-06 | 84 | 292 | 7 | 15203218 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | SVEP1 SPON2 CCN3 HSPG2 NID2 VWF OLFML2B IFNAR2 PAPPA LTBP2 MSLN | 9.12e-06 | 248 | 292 | 11 | 24006456 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYT1L MYT1 SREBF1 EZH1 EZH2 PGR STAT6 NFATC2 NFE2L2 KMT2A OLIG1 HOMEZ CENPT UNCX FOXN4 E2F1 TFAP2A MIXL1 ZNF335 SETBP1 NFXL1 SNAPC4 | 1.03e-05 | 908 | 292 | 22 | 19274049 |
| Pubmed | 1.15e-05 | 6 | 292 | 3 | 18787040 | ||
| Pubmed | TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation. | 1.15e-05 | 6 | 292 | 3 | 24244024 | |
| Pubmed | An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. | 1.15e-05 | 6 | 292 | 3 | 24509082 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.49e-05 | 170 | 292 | 9 | 23314748 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | ASXL1 DDX42 CEP76 EDC4 TTN ITPR1 EHMT2 SVIL GNAS KNL1 CRTAP KIF23 HDAC6 CANX BSDC1 SMTN TUBGCP6 GTF3C1 MAP1S INF2 TNKS1BP1 DIXDC1 ASXL2 ESPL1 CCDC9 | 1.74e-05 | 1155 | 292 | 25 | 20360068 |
| Pubmed | MYT1L DDX42 TTN STAT6 ITPR1 BOD1L1 TASOR LARGE2 TICRR RHBDF1 HDAC6 DBNL SMURF1 HIPK2 DIS3 SMTN IGF2R ZSCAN10 INF2 NFXL1 TMPRSS2 ASXL2 PATJ ESPL1 | 1.79e-05 | 1084 | 292 | 24 | 11544199 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPPK1 APC2 ATG2A MDM2 TTN ZNF469 TNRC18 NFE2L2 CAMSAP1 EPN1 MAP1S NBPF9 SETBP1 PATJ | 1.93e-05 | 430 | 292 | 14 | 35044719 |
| Pubmed | USP9X MED14 MPDZ EDC4 KMT2A BOD1L1 TAF6 KIF23 DBNL BEND3 TFAP2A GTF3C1 TNKS1BP1 PATJ SYMPK HDLBP | 1.94e-05 | 549 | 292 | 16 | 38280479 | |
| Pubmed | 2.00e-05 | 7 | 292 | 3 | 16885194 | ||
| Pubmed | 2.56e-05 | 102 | 292 | 7 | 11214970 | ||
| Pubmed | Integrative predictive model of coronary artery calcification in atherosclerosis. | 2.66e-05 | 229 | 292 | 10 | 19948975 | |
| Pubmed | 3.18e-05 | 8 | 292 | 3 | 29155075 | ||
| Pubmed | Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. | 3.18e-05 | 8 | 292 | 3 | 19729839 | |
| Pubmed | DDX42 MED14 COMTD1 ATRIP BOD1L1 SAGE1 KNL1 KIF23 BEND3 DIS3 PHC1 SMTN GTF3C1 CCDC9 | 3.41e-05 | 453 | 292 | 14 | 29656893 | |
| Pubmed | 4.12e-05 | 75 | 292 | 6 | 20637190 | ||
| Pubmed | SREBF1 MPDZ C15orf39 EZH2 DDX3X ITPR1 RUSC2 KMT2A EPN1 TASOR DDX11L8 RALGDS DIS3 CEMIP GTF3C1 NFXL1 PATJ | 4.17e-05 | 650 | 292 | 17 | 38777146 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ARRDC1 TTN DDX3X RUSC2 SPON2 SYPL1 RAB29 SLC39A5 PTTG1IP HSPG2 MXRA5 VWF DBNL SMURF1 CR1 ABHD14B IGF2R MEGF8 TMPRSS2 PATJ MBD5 CRB2 | 5.58e-05 | 1016 | 292 | 22 | 19056867 |
| Pubmed | BCORL1 C15orf39 EHMT2 CAMSAP1 TASOR KNL1 HOMEZ POLH BEND3 PHC1 GTF3C1 CTBP2 TNKS1BP1 | 6.09e-05 | 418 | 292 | 13 | 34709266 | |
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | MED14 F2 DDX3X UBE2E1 HMCN2 SEMA5B EFCAB12 NPAP1 TBPL2 OLFML2B SMURF1 MIXL1 | 6.21e-05 | 361 | 292 | 12 | 18976975 |
| Pubmed | 6.73e-05 | 10 | 292 | 3 | 21084607 | ||
| Interaction | TOP3B interactions | ABCA2 EPPK1 ANKRD37 SREBF1 MED14 C15orf39 ATG2A MDFI EDC4 COMTD1 REXO1 DDX3X TNRC18 SVIL NAV2 LRRC56 GNAS CAMSAP1 LRRC8E SEMA4F DPH2 HSPG2 KIF23 RHBDF1 SH3RF1 ZNF628 KHNYN LRRK1 REV3L ATP13A2 DENND1A NBPF1 CCNF IGF2R MAP1S MEGF8 INF2 ZNF335 DUSP16 TMEM268 TNKS1BP1 SNAPC4 MBD5 ZNF839 ESPL1 SYMPK HDLBP | 1.26e-07 | 1470 | 286 | 47 | int:TOP3B |
| Interaction | GNB1 interactions | ASXL1 MDM2 EZH2 SVIL GNAS TAF6 KIF23 HDAC6 CANX SMURF1 PLEKHG2 REV3L VIRMA CEMIP CCNF TMPRSS2 PIK3R5 HDLBP | 4.46e-07 | 307 | 286 | 18 | int:GNB1 |
| Interaction | RING1 interactions | BCORL1 UBE2E1 MTUS1 EHMT2 MN1 KIF23 E2F1 VIRMA PHC1 IFNAR2 UBE2D4 MSLN HDLBP | 6.33e-06 | 201 | 286 | 13 | int:RING1 |
| Interaction | HIPK1 interactions | 1.71e-05 | 39 | 286 | 6 | int:HIPK1 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.47e-09 | 57 | 179 | 9 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | NFASC TTN CADM2 IGSF10 TYRO3 HMCN2 ADGRF5 MERTK HSPG2 MXRA5 ROR1 HMCN1 WFIKKN1 | 7.57e-09 | 161 | 179 | 13 | 593 |
| GeneFamily | Neuroblastoma breakpoint family | 7.60e-08 | 23 | 179 | 6 | 662 | |
| GeneFamily | Immunoglobulin like domain containing | AXL TTN TYRO3 HMCN2 VSIG10L ADGRF5 MERTK HSPG2 ISLR2 MXRA5 IL6R | 3.59e-06 | 193 | 179 | 11 | 594 |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.98e-05 | 34 | 179 | 5 | 487 | |
| GeneFamily | Fibulins | 5.15e-05 | 8 | 179 | 3 | 556 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 7.67e-05 | 9 | 179 | 3 | 1223 | |
| GeneFamily | Pappalysins|Sushi domain containing | 9.75e-05 | 2 | 179 | 2 | 897 | |
| GeneFamily | Zinc fingers C2H2C-type | 2.91e-04 | 3 | 179 | 2 | 1261 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 6.43e-04 | 40 | 179 | 4 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 1.09e-03 | 160 | 179 | 7 | 555 | |
| GeneFamily | Lysine methyltransferases|Myb/SANT domain containing|Polycomb repressive complex 2 | 1.42e-03 | 6 | 179 | 2 | 1347 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.86e-03 | 53 | 179 | 4 | 532 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SSPOP SVEP1 IGSF10 FNDC7 HMCN2 SPON2 CCN3 NID2 FBLN7 MXRA5 VWF TSPEAR HMCN1 LTBP2 FBN3 | 6.20e-09 | 196 | 292 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | SSPOP SVEP1 IGSF10 FNDC7 HMCN2 SPON2 CCN3 HSPG2 NID2 FBLN7 MXRA5 VWF TSPEAR COL5A3 HMCN1 LTBP2 FBN3 | 1.50e-08 | 275 | 292 | 17 | M5884 |
| Coexpression | NABA_MATRISOME | F2 SSPOP SVEP1 IGSF10 FNDC7 HMCN2 IL1F10 SEMA5B SPON2 CCN3 PAPPA2 SEMA4F VWC2 HSPG2 NID2 FBLN7 MXRA5 VWF TSPEAR COL5A3 REG1B ADAMTS13 FCN3 HMCN1 MEGF8 CLEC17A WFIKKN1 LPA PAPPA LTBP2 FBN3 ADAMTSL2 | 1.72e-07 | 1026 | 292 | 32 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | SSPOP SVEP1 IGSF10 FNDC7 HMCN2 SPON2 CCN3 NID2 FBLN7 VWF TSPEAR HMCN1 LTBP2 | 2.54e-07 | 191 | 292 | 13 | MM17059 |
| Coexpression | NABA_CORE_MATRISOME | SSPOP SVEP1 IGSF10 FNDC7 HMCN2 SPON2 CCN3 HSPG2 NID2 FBLN7 VWF TSPEAR COL5A3 HMCN1 LTBP2 | 4.23e-07 | 270 | 292 | 15 | MM17057 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | ARRDC1 AXL USP9X C1RL COMTD1 CADM2 TYRO3 MTUS1 NFATC2 SVIL PTPRQ NAV2 MN1 SLX1A HSPG2 RALGDS OLFML2B FAM221A SEZ6L2 THBD INF2 NBPF9 PAPPA LTBP2 FBN3 IL6R MSLN CRB2 TPBG | 1.15e-06 | 955 | 292 | 29 | M45680 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MYT1 MED14 PIDD1 NFASC EZH2 BICD1 PASK KIF5C CAMSAP1 UNC79 DDX11L8 CCN3 KNL1 TICRR KIF23 PCDHB10 REV3L SEZ6L2 DIS3 PHC1 PCDHB18P KIF18B | 9.00e-06 | 680 | 292 | 22 | MM456 |
| Coexpression | NABA_MATRISOME | F2 SSPOP SVEP1 IGSF10 FNDC7 HMCN2 IL1F10 SEMA5B SPON2 CCN3 PAPPA2 SEMA4F VWC2 HSPG2 NID2 FBLN7 VWF TSPEAR COL5A3 REG1B ADAMTS13 HMCN1 MEGF8 WFIKKN1 LPA PAPPA LTBP2 ADAMTSL2 | 9.52e-06 | 1008 | 292 | 28 | MM17056 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.82e-05 | 166 | 292 | 10 | M6826 | |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN | 1.90e-05 | 133 | 292 | 9 | M8181 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP | MFSD6 RCSD1 GPR63 TTC7B KIF23 PLEKHG2 TNKS1BP1 PATJ PIK3R5 IL6R | 2.73e-05 | 174 | 292 | 10 | M380 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 4.98e-05 | 59 | 292 | 6 | M47989 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP | 5.02e-05 | 86 | 292 | 7 | M19610 | |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | RUSC2 TTC7B KNL1 RHBDF1 REV3L ATP13A2 CCNF CTBP2 KIF18B PGM2 | 5.04e-05 | 187 | 292 | 10 | M6807 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | PLK5 RCSD1 SVEP1 MTUS1 NFATC2 SEMA5B NFE2L2 SVIL SORCS2 GNAS OLIG1 CCN3 VWC2 NID2 TICRR FBLN7 KIF23 ROR1 LRRK1 CEMIP THBD HMCN1 GUCY2D PAPPA KIF18B PIK3R5 TPBG | 7.65e-05 | 1074 | 292 | 27 | M1941 |
| Coexpression | GSE7852_TREG_VS_TCONV_LN_DN | MFSD6 ITPR1 NFE2L2 MN1 SEMA4F SELENOP EFCAB6 MAMDC4 HSPB9 PIK3R5 | 8.48e-05 | 199 | 292 | 10 | M5729 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | MYT1L MYT1 APC2 F2 SSPOP SVEP1 RUSC2 ZNF469 SPON2 EFCAB12 SORCS2 GRIN3B NNMT GLTPD2 MN1 SLC39A5 PAPPA2 ZNF703 NID2 FBLN7 SELENOP MXRA5 DRP2 UNCX FOXN4 COL5A3 HMCN1 NBPF9 SETBP1 PAPPA LTBP2 CRB2 | 2.66e-05 | 1094 | 283 | 32 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.72e-05 | 146 | 283 | 10 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | ANKRD37 USP9X MED14 PLSCR2 KIF5C RELCH UNCX CANX HIPK2 REV3L TFAP2A INMT TMPRSS2 DIXDC1 ASXL2 PATJ HDLBP | 3.51e-05 | 406 | 283 | 17 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 3.73e-05 | 94 | 283 | 8 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 4.79e-05 | 156 | 283 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_200 | 5.79e-05 | 51 | 283 | 6 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_200_k4 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Mesoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | MYT1 TTN CADM2 HMCN2 SEMA5B NPAP1 PLSCR2 UNC79 LARGE2 VWF TSPEAR ZSCAN10 MIXL1 DENND2C TMPRSS2 PIK3R5 FBN3 RFPL2 | 1.09e-04 | 489 | 283 | 18 | PCBC_MESO-5_fibroblast_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | ZBTB20 USP9X MFSD6 MED14 GPR63 EZH1 ITPR1 UBE2E1 LARGE2 RELCH UNCX SLC38A4 CANX HIPK2 LRRK1 REV3L TFAP2A INMT TENM1 TMPRSS2 DIXDC1 ASXL2 PATJ HDLBP | 1.19e-04 | 774 | 283 | 24 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_500 | 1.26e-04 | 20 | 283 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k3_500 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 CSMD3 SSPOP TTN CADM2 NRK PTPRQ UNC79 DRP2 EFCAB6 HMCN1 TENM1 | 3.60e-09 | 184 | 292 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 CSMD3 SSPOP TTN CADM2 NRK PTPRQ UNC79 DRP2 EFCAB6 HMCN1 TENM1 | 3.60e-09 | 184 | 292 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 CSMD3 SSPOP TTN CADM2 NRK PTPRQ UNC79 DRP2 EFCAB6 HMCN1 TENM1 | 3.60e-09 | 184 | 292 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | SHROOM4 HMCN2 MTUS1 GALNT8 ADGRF5 HSPG2 MXRA5 VWF FOXN4 ATP13A2 INMT RFLNA | 4.07e-09 | 186 | 292 | 12 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | SIGLEC9 ZNF683 RCSD1 EZH2 NFATC2 KNL1 TICRR E2F1 CCNF KIF18B ESPL1 PIK3R5 | 4.33e-09 | 187 | 292 | 12 | 73931a5ea73799095daff100b5f18853c57c74dc |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-07 | 159 | 292 | 10 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCDC9B MFSD6 TTN SHROOM4 PTPRQ EFCAB6 SLC38A4 E2F1 RFX6 CEMIP | 1.04e-07 | 159 | 292 | 10 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCDC9B MFSD6 TTN SHROOM4 PTPRQ EFCAB6 SLC38A4 E2F1 RFX6 CEMIP | 1.04e-07 | 159 | 292 | 10 | 7619d0d49738dd08daf01b42664691a5323aa793 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | CADM2 BICD1 SEMA4F HSPG2 ITGA10 TFAP2A CEMIP PAPPA RFLNA ESPL1 | 3.64e-07 | 182 | 292 | 10 | a1c0e4090a9e7aa4941a40c817d178de144888b6 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | NNMT RALGDS TSPEAR C1orf167 CR1 CEMIP THBD HMCN1 LTBP2 SNAPC4 | 3.64e-07 | 182 | 292 | 10 | f231e86524b628e6e11ac33d5c34be99d454a92a |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.25e-07 | 142 | 292 | 9 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.30e-07 | 104 | 292 | 8 | 424a58b04c8b5108b70f15d8353c8e4b9db1e730 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.30e-07 | 104 | 292 | 8 | 11d91471b6c4fa6b00a91d9fd4db72ee60d1f801 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Mgp_(Mgp)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.30e-07 | 104 | 292 | 8 | 9b05ae514437eb0c8b1b23607ae8cbc371ffa85b | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.45e-07 | 186 | 292 | 10 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | ITPR1 SHROOM4 ADGRF5 HSPG2 VWF ITGA10 HIPK2 DENND1A HMCN1 SETBP1 | 5.15e-07 | 189 | 292 | 10 | c81787a8c662db5d7814c583dd64562857629e81 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.67e-07 | 191 | 292 | 10 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-07 | 195 | 292 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.86e-07 | 195 | 292 | 10 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-07 | 195 | 292 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | ITPR1 NFATC2 SPON2 KMT2A BOD1L1 GNAS IGF2R GTF3C1 NBPF10 PIK3R5 | 7.18e-07 | 196 | 292 | 10 | 7bced0cc2112697593c478fa291b8ed3941fb811 |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ABCA2 NFASC SEMA5B GALNT8 ADGRF5 KIF5C RAB29 RALGDS COL5A3 NBPF10 | 7.53e-07 | 197 | 292 | 10 | 06e17c9ad53463eee1007280b3f3e8b0cf446cdc |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.53e-07 | 197 | 292 | 10 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.25e-07 | 199 | 292 | 10 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.64e-07 | 200 | 292 | 10 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.64e-07 | 200 | 292 | 10 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.64e-07 | 200 | 292 | 10 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.64e-07 | 200 | 292 | 10 | c800f20adedf4ca736c740510889e92d8bf0ba44 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.64e-07 | 200 | 292 | 10 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.64e-07 | 200 | 292 | 10 | bf50e30d5cafb71c567e89580f62084d2f894170 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | CSMD3 ZNF469 LRRC8E VWC2 NID2 MXRA5 EFCAB6 PRR22 NBPF9 RFPL2 | 8.64e-07 | 200 | 292 | 10 | fe772d98c461c973dfc082e1fc50117c27ced804 |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.64e-07 | 200 | 292 | 10 | 5e5ad07679d5dd2ca80249bce9aaf4a95d42187b | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.10e-06 | 159 | 292 | 9 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-06 | 167 | 292 | 9 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | MTUS1 NFE2L2 SYPL1 FBXO34 DIS3 IFNAR2 DENND2C TNKS1BP1 FAM83A | 2.01e-06 | 171 | 292 | 9 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-06 | 174 | 292 | 9 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-06 | 174 | 292 | 9 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-06 | 174 | 292 | 9 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.43e-06 | 175 | 292 | 9 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 175 | 292 | 9 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 177 | 292 | 9 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 177 | 292 | 9 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 178 | 292 | 9 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-06 | 180 | 292 | 9 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | droplet-Kidney-nan-3m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-06 | 181 | 292 | 9 | 0b1e7335648823b1d83bdfa878ccd44efe7bba9a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.28e-06 | 136 | 292 | 8 | a43b3db1754c619d328a26a2ba6af4756629a723 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-06 | 182 | 292 | 9 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-06 | 185 | 292 | 9 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.18e-06 | 187 | 292 | 9 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.18e-06 | 187 | 292 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-06 | 187 | 292 | 9 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-06 | 187 | 292 | 9 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.36e-06 | 188 | 292 | 9 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.36e-06 | 188 | 292 | 9 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.96e-06 | 191 | 292 | 9 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.96e-06 | 191 | 292 | 9 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 4.96e-06 | 191 | 292 | 9 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.96e-06 | 191 | 292 | 9 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.96e-06 | 191 | 292 | 9 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.02e-06 | 144 | 292 | 8 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | droplet-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-06 | 145 | 292 | 8 | f142b86d4da5b71c189da46cbc4beebdc387ffee | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 5.40e-06 | 193 | 292 | 9 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-06 | 194 | 292 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.63e-06 | 194 | 292 | 9 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.63e-06 | 194 | 292 | 9 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 5.63e-06 | 194 | 292 | 9 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 5.63e-06 | 194 | 292 | 9 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 5.87e-06 | 195 | 292 | 9 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 343B|World / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-06 | 195 | 292 | 9 | 2290911fde6efacfa38b985a2541322968bee42d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-06 | 196 | 292 | 9 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | Healthy-T/NK_proliferative|Healthy / disease group, cell group and cell class | 6.12e-06 | 196 | 292 | 9 | 91e44aabb2e85dcc77ddae6f7e000118d45d1de6 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.12e-06 | 196 | 292 | 9 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-06 | 197 | 292 | 9 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.38e-06 | 197 | 292 | 9 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.38e-06 | 197 | 292 | 9 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 6.38e-06 | 197 | 292 | 9 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-06 | 197 | 292 | 9 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.38e-06 | 197 | 292 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.38e-06 | 197 | 292 | 9 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.38e-06 | 197 | 292 | 9 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-06 | 197 | 292 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.38e-06 | 197 | 292 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.38e-06 | 197 | 292 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.38e-06 | 197 | 292 | 9 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.38e-06 | 197 | 292 | 9 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.38e-06 | 197 | 292 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.46e-06 | 149 | 292 | 8 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.46e-06 | 149 | 292 | 8 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.64e-06 | 198 | 292 | 9 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.64e-06 | 198 | 292 | 9 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.64e-06 | 198 | 292 | 9 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.76e-06 | 107 | 292 | 7 | d446ffbe93cd49669f1cf91411aae07cc15d9e2a | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Il33_(Il33)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.76e-06 | 107 | 292 | 7 | 5c9e745d0b08a4aa1f3a93f9cc094fac57061a30 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 6.92e-06 | 199 | 292 | 9 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 6.92e-06 | 199 | 292 | 9 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.92e-06 | 199 | 292 | 9 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-06 | 199 | 292 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-06 | 199 | 292 | 9 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 6.92e-06 | 199 | 292 | 9 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.92e-06 | 199 | 292 | 9 | d95d78b2ebc9a20532466e4d4be579b4faf6776f | |
| Disease | Liver carcinoma | SREBF1 EZH2 F2 MTUS1 NFE2L2 KMT2A NNMT TICRR KIF23 OLFML2B E2F1 ADAMTS13 FCN3 CCNF IGF2R INMT LPA KIF18B | 1.91e-06 | 507 | 279 | 18 | C2239176 |
| Disease | Thrombosis | 6.73e-06 | 49 | 279 | 6 | C0040053 | |
| Disease | myelofibrosis (is_implicated_in) | 4.52e-05 | 8 | 279 | 3 | DOID:4971 (is_implicated_in) | |
| Disease | familial Mediterranean fever (is_marker_for) | 6.74e-05 | 9 | 279 | 3 | DOID:2987 (is_marker_for) | |
| Disease | Thrombus | 7.28e-05 | 46 | 279 | 5 | C0087086 | |
| Disease | total lipids in large HDL | 7.32e-05 | 74 | 279 | 6 | EFO_0022189 | |
| Disease | thrombophilia (implicated_via_orthology) | 8.91e-05 | 2 | 279 | 2 | DOID:2452 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of prostate | ZBTB20 MDM2 EZH2 ITPR1 NFE2L2 SPON2 KMT2A ALOX12B SELENOP HDAC6 COL5A3 RFX6 IGF2R TMPRSS2 CTBP2 PATJ TPBG | 9.03e-05 | 616 | 279 | 17 | C0376358 |
| Disease | Prostatic Neoplasms | ZBTB20 MDM2 EZH2 ITPR1 NFE2L2 SPON2 KMT2A ALOX12B SELENOP HDAC6 COL5A3 RFX6 IGF2R TMPRSS2 CTBP2 PATJ TPBG | 9.03e-05 | 616 | 279 | 17 | C0033578 |
| Disease | Malignant neoplasm of breast | TRIML1 ABCA4 APC2 BCORL1 MED14 MDM2 EZH2 DDX3X PGR SEMA5B BOD1L1 NID2 VWF POLH ROR1 E2F1 APOC4 MAMDC4 TFAP2A NSUN6 UNC45B SETBP1 TENM1 HDLBP | 9.66e-05 | 1074 | 279 | 24 | C0006142 |
| Disease | cholesterol in large HDL measurement | 1.13e-04 | 80 | 279 | 6 | EFO_0021900 | |
| Disease | Thromboembolism | 1.73e-04 | 12 | 279 | 3 | C0040038 | |
| Disease | body weight | MYT1L CCDC9B CADM2 BICD1 ITPR1 NFATC2 GNAS PRMT7 RAB29 UNC79 BANK1 HOMEZ PAPPA2 NID2 RELCH SH3RF1 UNCX BSDC1 VIRMA DENND1A HHLA2 SETBP1 PAPPA LTBP2 PATJ TPBG | 1.79e-04 | 1261 | 279 | 26 | EFO_0004338 |
| Disease | high density lipoprotein particle size measurement | 2.26e-04 | 170 | 279 | 8 | EFO_0008592 | |
| Disease | Chromosome Breakage | 2.82e-04 | 14 | 279 | 3 | C0376628 | |
| Disease | Chromosome Breaks | 2.82e-04 | 14 | 279 | 3 | C0333704 | |
| Disease | Autosomal recessive primary microcephaly | 3.50e-04 | 15 | 279 | 3 | cv:C3711387 | |
| Disease | severe acute respiratory syndrome, COVID-19 | USP9X NFASC RCSD1 REXO1 DNAAF3 SEMA5B SORCS2 TBPL2 MXRA5 CTBP2 LTBP2 PATJ PGM2 | 3.69e-04 | 447 | 279 | 13 | EFO_0000694, MONDO_0100096 |
| Disease | obesity (is_marker_for) | 4.05e-04 | 101 | 279 | 6 | DOID:9970 (is_marker_for) | |
| Disease | Huntington's disease (biomarker_via_orthology) | 4.28e-04 | 16 | 279 | 3 | DOID:12858 (biomarker_via_orthology) | |
| Disease | C-reactive protein measurement | RNF144B SIGLEC9 CCDC168 SSPOP ITPR1 ZNF469 IL1F10 NFE2L2 MERTK BANK1 CCN3 VWC2 FBLN7 OLFML2B SLC38A4 APOC4 LPA PCIF1 TNKS1BP1 SNAPC4 PATJ IL6R GALNT4 HDLBP | 5.26e-04 | 1206 | 279 | 24 | EFO_0004458 |
| Disease | coffee consumption measurement, Cannabis use | 5.28e-04 | 4 | 279 | 2 | EFO_0006781, EFO_0007585 | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 5.28e-04 | 4 | 279 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | Chromosome 2q37 deletion syndrome | 5.28e-04 | 4 | 279 | 2 | C2931817 | |
| Disease | Sotos' syndrome | 5.28e-04 | 4 | 279 | 2 | C0175695 | |
| Disease | Familial Thrombotic Thrombocytopenic Purpura | 5.28e-04 | 4 | 279 | 2 | C1956258 | |
| Disease | Congenital Thrombotic Thrombocytopenic Purpura | 5.28e-04 | 4 | 279 | 2 | C1268935 | |
| Disease | Purpura, Thrombotic Thrombocytopenic | 5.28e-04 | 4 | 279 | 2 | C0034155 | |
| Disease | triglycerides to total lipids in small HDL percentage | 6.08e-04 | 72 | 279 | 5 | EFO_0022336 | |
| Disease | sphingosine 1-phosphate measurement | 6.14e-04 | 18 | 279 | 3 | EFO_0800185 | |
| Disease | phospholipids in large HDL measurement | 6.48e-04 | 73 | 279 | 5 | EFO_0022190 | |
| Disease | Juvenile Myelomonocytic Leukemia | 7.24e-04 | 19 | 279 | 3 | C0349639 | |
| Disease | carotid artery disease (is_marker_for) | 7.24e-04 | 19 | 279 | 3 | DOID:3407 (is_marker_for) | |
| Disease | Weaver syndrome | 8.74e-04 | 5 | 279 | 2 | C0265210 | |
| Disease | viral infectious disease (implicated_via_orthology) | 8.74e-04 | 5 | 279 | 2 | DOID:934 (implicated_via_orthology) | |
| Disease | chronic myelomonocytic leukemia (is_implicated_in) | 8.74e-04 | 5 | 279 | 2 | DOID:0080188 (is_implicated_in) | |
| Disease | Primary microcephaly | 1.13e-03 | 22 | 279 | 3 | C0431350 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 1.30e-03 | 6 | 279 | 2 | DOID:13809 (is_marker_for) | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 1.30e-03 | 6 | 279 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | Metastatic melanoma | 1.71e-03 | 54 | 279 | 4 | C0278883 | |
| Disease | Seckel syndrome (implicated_via_orthology) | 1.81e-03 | 7 | 279 | 2 | DOID:0050569 (implicated_via_orthology) | |
| Disease | grapefruit juice consumption measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0010094 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | pancreatic cancer (biomarker_via_orthology) | 1.81e-03 | 7 | 279 | 2 | DOID:1793 (biomarker_via_orthology) | |
| Disease | obsolete_Fms-related tyrosine kinase 3 ligand measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0010594 | |
| Disease | Disseminated Intravascular Coagulation | 1.81e-03 | 7 | 279 | 2 | C0012739 | |
| Disease | proactivator polypeptide-like 1 measurement | 1.81e-03 | 7 | 279 | 2 | EFO_0801912 | |
| Disease | cholesterol to total lipids in large HDL percentage | 1.83e-03 | 55 | 279 | 4 | EFO_0022234 | |
| Disease | ceramide measurement | 1.87e-03 | 235 | 279 | 8 | EFO_0010222 | |
| Disease | Neurodevelopmental Disorders | 1.92e-03 | 93 | 279 | 5 | C1535926 | |
| Disease | triglycerides in very large VLDL measurement | 1.95e-03 | 56 | 279 | 4 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.95e-03 | 56 | 279 | 4 | EFO_0022333 | |
| Disease | Endometrial Neoplasms | 2.22e-03 | 58 | 279 | 4 | C0014170 | |
| Disease | triglycerides in VLDL measurement | 2.37e-03 | 59 | 279 | 4 | EFO_0022326 | |
| Disease | sarcoma (is_implicated_in) | 2.40e-03 | 8 | 279 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | response to statin, low density lipoprotein cholesterol measurement | 2.40e-03 | 8 | 279 | 2 | EFO_0004611, GO_0036273 | |
| Disease | Varicose veins | 2.50e-03 | 193 | 279 | 7 | HP_0002619 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.52e-03 | 60 | 279 | 4 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 2.52e-03 | 60 | 279 | 4 | EFO_0022237 | |
| Disease | IGF-1 measurement | DDX42 ALDH16A1 SORCS2 GNAS PAPPA2 TICRR SELENOP IGF2R DCP1B LPA ASXL2 HDLBP | 2.54e-03 | 488 | 279 | 12 | EFO_0004627 |
| Disease | free cholesterol in HDL measurement | 2.67e-03 | 61 | 279 | 4 | EFO_0022264 | |
| Disease | triglycerides in small HDL measurement | 2.84e-03 | 62 | 279 | 4 | EFO_0022158 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.84e-03 | 62 | 279 | 4 | EFO_0022339 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.91e-03 | 148 | 279 | 6 | C0279702 | |
| Disease | Colorectal Carcinoma | CCDC9B ABCA4 APC2 CSMD3 MYLK3 NPAP1 GNAS RALGDS SELENOP RELCH TSPEAR SMTN SETBP1 TENM1 PIK3R5 | 3.01e-03 | 702 | 279 | 15 | C0009402 |
| Disease | Thrombophilia | 3.07e-03 | 9 | 279 | 2 | C0398623 | |
| Disease | sialic acid-binding ig-like lectin 7 measurement | 3.07e-03 | 9 | 279 | 2 | EFO_0020739 | |
| Disease | cholesterol in large VLDL measurement | 3.37e-03 | 65 | 279 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.37e-03 | 65 | 279 | 4 | EFO_0022230 | |
| Disease | fibrinogen measurement, coronary artery disease | 3.54e-03 | 154 | 279 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | coronary artery disease (is_marker_for) | 3.76e-03 | 67 | 279 | 4 | DOID:3393 (is_marker_for) | |
| Disease | venous thromboembolism, fibrinogen measurement | 3.76e-03 | 67 | 279 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | Non-Small Cell Lung Carcinoma | 3.78e-03 | 156 | 279 | 6 | C0007131 | |
| Disease | disseminated intravascular coagulation (is_marker_for) | 3.81e-03 | 10 | 279 | 2 | DOID:11247 (is_marker_for) | |
| Disease | Focal segmental glomerulosclerosis | 3.81e-03 | 10 | 279 | 2 | cv:C0017668 | |
| Disease | f-box/LRR-repeat protein 4 measurement | 3.81e-03 | 10 | 279 | 2 | EFO_0802538 | |
| Disease | Inherited focal segmental glomerulosclerosis | 3.81e-03 | 10 | 279 | 2 | cv:CN327126 | |
| Disease | disposition index measurement, glucose homeostasis measurement | 3.81e-03 | 10 | 279 | 2 | EFO_0006832, EFO_0006896 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.96e-03 | 68 | 279 | 4 | EFO_0022327 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 4.14e-03 | 111 | 279 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | coronary aneurysm | 4.38e-03 | 35 | 279 | 3 | EFO_1000881 | |
| Disease | sexual dimorphism measurement | EPPK1 RAB29 TASOR BANK1 PAPPA2 SELENOP E2F1 ADAMTS13 SEZ6L2 ATP13A2 INTS10 LPA ZNF335 PCIF1 PAPPA ASXL2 LTBP2 RFLNA PATJ HDLBP | 4.50e-03 | 1106 | 279 | 20 | EFO_0021796 |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 4.63e-03 | 71 | 279 | 4 | EFO_0022259 | |
| Disease | microfibrillar-associated protein 2 measurement | 4.63e-03 | 11 | 279 | 2 | EFO_0801801 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 4.63e-03 | 11 | 279 | 2 | cv:CN043612 | |
| Disease | Nephroblastoma | 4.74e-03 | 36 | 279 | 3 | C0027708 | |
| Disease | cortical thickness | ABCA4 SREBF1 DNAAF3 DUOX1 ZNF469 NAV2 KMT2A OLIG1 RAB29 BANK1 HSPG2 FBLN7 ROR1 BEND3 MINDY2 ATP13A2 DENND1A SHARPIN CTBP2 CRB2 | 4.82e-03 | 1113 | 279 | 20 | EFO_0004840 |
| Disease | Endometrial Carcinoma | 4.86e-03 | 72 | 279 | 4 | C0476089 | |
| Disease | electrocardiography | RNF144B AXL TTN DNAAF3 HMCN2 GALNT8 SVIL NAV2 RAB29 OLFML2B CEMIP SETBP1 | 4.89e-03 | 530 | 279 | 12 | EFO_0004327 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 5.10e-03 | 166 | 279 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 5.12e-03 | 37 | 279 | 3 | EFO_0022281 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 5.36e-03 | 74 | 279 | 4 | EFO_0022280 | |
| Disease | Pulmonary Thromboembolisms | 5.52e-03 | 12 | 279 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 5.52e-03 | 12 | 279 | 2 | C0034065 | |
| Disease | age of onset of multiple sclerosis | 5.52e-03 | 12 | 279 | 2 | OBA_2001029 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 5.78e-03 | 225 | 279 | 7 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides to total lipids in large VLDL percentage | 5.94e-03 | 39 | 279 | 3 | EFO_0022332 | |
| Disease | phospholipids:total lipids ratio | 6.05e-03 | 227 | 279 | 7 | EFO_0020946 | |
| Disease | neuroimaging measurement, brain volume measurement | 6.12e-03 | 286 | 279 | 8 | EFO_0004346, EFO_0006930 | |
| Disease | Leukemia, Myelocytic, Acute | 6.22e-03 | 173 | 279 | 6 | C0023467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLQTPELPSECNVGP | 176 | A8MWP4 | |
| LPTEIPCENPGEIFI | 201 | Q8NDB2 | |
| QDCQTEAPPLRGQVP | 191 | O95429 | |
| ALDDLLLQDGPCPQP | 956 | Q6UXC1 | |
| QEPCRVQTNLASPGP | 256 | Q5SNV9 | |
| LTVAPPDCQQPAASV | 916 | Q96G01 | |
| PAASVPPQCSQLAGR | 926 | Q96G01 | |
| QECPDPEPFANGIVR | 2121 | Q7Z408 | |
| NRNVPPQCVPVTCPD | 2581 | Q7Z408 | |
| DGAPPVCQVLCPANE | 2446 | Q7Z407 | |
| AQGPLKDAPNLICTP | 306 | P56545 | |
| NQNSCPPVVPRLDLG | 56 | Q9BXY5 | |
| SNLPPASPCAQVEVP | 386 | Q8IZ83 | |
| EPECPGPQLNTGTQL | 1336 | P78363 | |
| EGEPGPQSPCEENLV | 251 | Q9NW68 | |
| RPLALCEPGVNPEEQ | 321 | Q155Q3 | |
| DQPSILNSCEDPVPG | 466 | Q9NWN3 | |
| LLIPNQEACSGPGAP | 56 | O96024 | |
| PNGFLPNNLEEPACL | 1396 | Q5H9F3 | |
| NSRPNPILEPGIQSC | 361 | P05549 | |
| VLEPGCSPQTGPAQL | 376 | Q6JBY9 | |
| QPILAPCELEAACNP | 356 | Q9BQC3 | |
| ENVPIPCVNGVDGEP | 931 | Q96KQ7 | |
| HLQEPEPLPGQVCST | 121 | Q8TAP6 | |
| AAPVPGDRQCPTCVQ | 316 | Q8N6Q3 | |
| ACQPEAQEGTLSPPP | 26 | P55056 | |
| PELCPPRGSNEFQQL | 331 | Q75N90 | |
| PVLGLPQTCQEPESI | 176 | Q569K6 | |
| LAELQPPVQLPAEGC | 381 | Q5T5Y3 | |
| TVAAGCPDQSPELQP | 31 | Q8WUJ3 | |
| LGLCPSKTPINENAP | 16 | Q6NXP0 | |
| QILVPALPQSALPGC | 241 | Q8N5I2 | |
| AQEEPPEPPLQIGSC | 241 | Q2TAZ0 | |
| ASQLPVAPTGDQPCQ | 746 | Q8IXJ9 | |
| VAPTGDQPCQALPLL | 751 | Q8IXJ9 | |
| RELLPCGPETQPQSE | 741 | Q76L83 | |
| LDTQCQGLPRPEPQE | 991 | Q76LX8 | |
| QGLPRPEPQEACSLE | 996 | Q76LX8 | |
| RDTCLGPQAQAPVPA | 1096 | Q76LX8 | |
| LLETGASVNAPPDPC | 16 | Q7Z713 | |
| PDSIACASPPALQGV | 206 | Q6UXK2 | |
| GQDPALEVEQCSCPP | 1116 | P98160 | |
| TLAPGQIDPEATCPA | 1201 | Q9H0J4 | |
| TLPNGEPVPCLLLAN | 111 | O14966 | |
| PAPQLSPGIQEDCCV | 16 | Q8HWS3 | |
| LLVEQPLAEEQPPCG | 516 | Q9C0H5 | |
| VCETVDPAQVFGQPP | 1296 | Q6P2E9 | |
| LQPPAAQGTPEPCVQ | 211 | Q9H0B3 | |
| FVCPSQPPPGAEQLQ | 376 | Q8N3Y3 | |
| EGLARPKQPLASPCQ | 211 | Q8WV74 | |
| GPNAPSQVPLVLLED | 336 | Q9NVR2 | |
| ETPAPEQPAECQPLL | 611 | A6NDB9 | |
| EQPAECQPLLQGEGP | 616 | A6NDB9 | |
| ELCGPTEPCVLPFQV | 96 | Q9Y5E7 | |
| PLQNGSAPCTELVPR | 566 | Q9Y5E7 | |
| PLQNGSAPCTELVPR | 511 | Q96TA0 | |
| PVASSDPGQPVLVEC | 131 | Q7Z419 | |
| SQLPGFVPVAPICTD | 126 | Q96IU4 | |
| IPQPDFEVPGADCLL | 541 | Q5T5X7 | |
| PQPRQLSTEGLPACA | 566 | Q9NRD9 | |
| AIPAVCDSVQPPLDQ | 396 | Q9P260 | |
| IPVEATGNNCPPHIE | 166 | O00571 | |
| RVGPDALPVSCPALN | 71 | Q53RD9 | |
| ALPVSCPALNTPADG | 76 | Q53RD9 | |
| EPGDPVNLLRCQEGP | 76 | O75636 | |
| CAEALVALPPGASPQ | 256 | Q13469 | |
| FLCGPAEPQQPVQLT | 121 | Q8WWZ1 | |
| QLLSCLSPQPAPGVD | 476 | Q96RG2 | |
| PLQTGTAQICARPDP | 636 | Q9H2X6 | |
| NPPAQLPNSEGLCEF | 196 | Q66K74 | |
| QPCVPGETAPFQVRQ | 46 | A6NH11 | |
| EQPSEPAFIQTALPC | 616 | Q6ZNB6 | |
| LTCQAVGPPEPVNIF | 216 | Q12866 | |
| GPVNPAACRPAELLA | 126 | Q02846 | |
| GNPLAPAVLPLADCV | 146 | O95050 | |
| RCVVQPETGDLNNPP | 36 | Q14643 | |
| LCIQPQTAPDALPPE | 886 | Q9ULD2 | |
| VQELLESLPGPCSPQ | 136 | Q38SD2 | |
| QVPTLPCEANPCLNG | 1171 | Q5IJ48 | |
| VACAPGRVTIQEDPP | 286 | Q5VTL7 | |
| QPVTLQCIGDGVPTP | 1826 | Q8NDA2 | |
| VSLQCPALGNPVPTI | 2871 | Q8NDA2 | |
| QTALLPCQADGVPAP | 3701 | Q8NDA2 | |
| CVALALPEAQTGPSP | 131 | Q9BQS6 | |
| AECPGPAQNASPLVL | 366 | Q9UGM5 | |
| EVQTCPEPQRGAGLP | 471 | Q6ZUT6 | |
| PTPIQCQGVPVALSG | 276 | Q86XP3 | |
| ELTEQQLPGALPPEC | 246 | Q15910 | |
| CCLQEIEIQAPPGVP | 176 | Q9NRY7 | |
| CLQAPGTEPGEQTPE | 381 | Q32MK0 | |
| CDVTQSQPLGAVPLP | 141 | P40261 | |
| QCENTPEKELPVSPG | 421 | Q16236 | |
| GVLAVAPFPCIPESQ | 706 | Q6ZU69 | |
| GVLAVAPFPCIPESQ | 436 | Q63HN1 | |
| RCPSAPDNGEENVPL | 396 | Q9UM44 | |
| PVPQECVPQDGAAGA | 1416 | Q7Z7M0 | |
| ELCAPPGNSDPEQLK | 571 | Q96G03 | |
| QLCLDVGPPATQDPL | 181 | Q496M5 | |
| TVQPGCSLPSNPEAI | 236 | Q8N8J0 | |
| LPPVESEAAQSCQPK | 251 | P12525 | |
| PVGRQACDLQPCPTE | 896 | Q86TH1 | |
| GEAPDPVITSNVPCF | 1566 | Q8NG31 | |
| VATSPAPGPLQAAEC | 961 | Q96RT7 | |
| PRLVSCPGPLDQDQQ | 206 | Q13421 | |
| IQAQAREPPCPPDTL | 71 | Q86UY5 | |
| EAPCQQLLPRGIPEQ | 66 | Q6NSJ5 | |
| CLAPPPVPNADLQTA | 1346 | Q13219 | |
| LPLPEAAPAQAQAEA | 671 | Q9UN67 | |
| ENSPAGRAQPVPCET | 731 | Q6ZSS7 | |
| NPQPGEKILDLCAAP | 231 | Q8TEA1 | |
| SLALDEPPCGQFALP | 221 | Q8TAK6 | |
| CTPELPAGPRALQEE | 416 | Q86Y91 | |
| CQDAVNILPVPGPTS | 251 | Q3BBV0 | |
| ECQDAVNILPVPGPT | 521 | Q3BBV0 | |
| LTTEDPQCPQPLEGA | 1086 | Q27J81 | |
| QRVDIPCNAQGTPLP | 1186 | Q96RW7 | |
| NPVQLECKAAGNPVP | 1936 | Q96RW7 | |
| NIECRATGTPPPQIN | 3361 | Q96RW7 | |
| LNNPILLPCEATGTP | 4001 | Q96RW7 | |
| PKDSPQQLELLSGPC | 381 | P48551 | |
| PALVVPILEPCGNSE | 436 | O60244 | |
| LDPLGPLASEVCQQP | 316 | Q86Y26 | |
| VPEGPPQNCVTGNIT | 346 | Q9UMZ3 | |
| TCILITPPANPCEDG | 841 | Q14112 | |
| ARKLLQPENPCPGDQ | 421 | Q9NQV7 | |
| LDAVALPQPVGVPNE | 651 | P06401 | |
| VVQEGAPLTLQCNPP | 151 | O94856 | |
| LSPLQPPLCGQTVCD | 491 | Q9BXP8 | |
| PSLIAENNCRCPGPV | 2376 | Q8NFC6 | |
| PLSELPENRPCENGS | 306 | Q8IZD4 | |
| GSAPIPIEPQICQAT | 401 | O95996 | |
| SPELVAGLCNPETVP | 656 | Q9NQ11 | |
| QICSLSPEVLGPSPE | 336 | Q6ZSI9 | |
| AQVPCPPQLPEEELF | 1086 | Q14674 | |
| ALNCSVDGNPPPEII | 2356 | Q6WRI0 | |
| CGILQPDPPANITVT | 211 | P08887 | |
| GSDPLLPSNCEPVVS | 246 | Q9H4Z3 | |
| AGPCDPDLLLFATPQ | 56 | Q01094 | |
| LAQPQGALAPPNCES | 521 | Q8N9W5 | |
| LGQVAATQRCPPQCP | 26 | P48745 | |
| LCAALGVTQDSPDPP | 536 | P41002 | |
| IISCEPPPTISNGDF | 1516 | P17927 | |
| QVTVKLPNCAPGVDP | 91 | Q86YW7 | |
| IPGTPPLQNCDPIES | 1301 | Q5THR3 | |
| QQPVPLQPLCAEGTV | 586 | Q9NVM4 | |
| QAPEAAPTGIPCSEQ | 451 | Q9Y3X0 | |
| RNCSAAPQPEPAAGL | 86 | O75718 | |
| APSSPILGQPCGDDQ | 46 | Q9H4R4 | |
| QNCPKDGFPVPANII | 516 | Q8N4A0 | |
| ENVCLDQGPVPGNTP | 506 | Q9NY28 | |
| CISQPCLPVANIGPT | 146 | Q9BY84 | |
| SCGSLELQLPELEPP | 126 | Q96BT3 | |
| VTCEVDAQPPELGRP | 131 | Q86VU5 | |
| PPDNIPLVICSGISN | 656 | A8MPP1 | |
| LGPNVLPVCLPDNET | 351 | Q9NZP8 | |
| EAPQIANPRCESAPG | 351 | P27824 | |
| PFPQEGQPLILTCES | 236 | Q8N3J6 | |
| QETEPPSALQSPLGC | 2371 | Q9BZC7 | |
| VIQVPSLGPPSEQDC | 1706 | P08519 | |
| SEPEGQECGPSINPL | 196 | Q68D51 | |
| LQDCVEVSRPEGPAP | 56 | Q9GZL8 | |
| PTEAVTCQPQGNPLG | 81 | Q99750 | |
| PASPVIENGQLECPQ | 596 | Q14767 | |
| IQLSQTPGPDCPIFL | 356 | O75342 | |
| QQAPEPAVGLESAPA | 316 | Q12967 | |
| PCELQPRIDPSLGQQ | 1056 | Q9P267 | |
| NASCIVQNLTEPPGP | 1011 | O75578 | |
| ENGCAPTPEEQLPKT | 456 | Q8TEH3 | |
| QPPSCGPEDDAQLQL | 201 | Q9Y6I3 | |
| QDPFTLCLANVPGQP | 421 | O15037 | |
| LNPPPGIEDNRQCAL | 1861 | Q03164 | |
| GNPDLQIPSRAPQCV | 216 | Q9BZJ6 | |
| LQPLGCVPQSVSPSE | 306 | Q8IX15 | |
| PLPPVTGSNCQCNVE | 671 | Q8WXE1 | |
| IPVDQPPCSEGIHLN | 3236 | Q8NDH2 | |
| PIPAAGLDVTQPCGD | 1121 | Q9UBN7 | |
| TDLEAIPQQCPIDLP | 86 | A4D161 | |
| IPQQCPIDLPCQVTG | 91 | A4D161 | |
| LPDCDNLAPAATVAP | 221 | P25940 | |
| NLAPAATVAPQGEPE | 226 | P25940 | |
| EPAPSTPPCLVQAEE | 316 | Q9UJU6 | |
| DLILDQCPDRGAPVP | 251 | P59044 | |
| PITDREPAFGQQAPC | 761 | Q13474 | |
| PGPCSFQQLDESPAV | 426 | Q8N344 | |
| VSRPVSNACLVPPEG | 451 | Q9HB75 | |
| RLALGEALQCPSQPP | 1746 | Q5THK1 | |
| QTELPNPRISCPEGT | 26 | P48304 | |
| CGRLLFQPDQNAPPI | 791 | Q02241 | |
| VPAPCLPLDQSPNRA | 186 | Q10571 | |
| LEDVALLQAPQPPAC | 106 | Q9Y4I5 | |
| AEGAPPLCNLQPLEA | 251 | Q7Z2Y5 | |
| LLPAPVNCGDLQPAG | 316 | O60391 | |
| VAHGCLAVSQLPPQP | 336 | Q96NZ1 | |
| INVCGPVSVSPCQPD | 661 | P11717 | |
| PIITQNENGPCPLLA | 256 | Q8NBR6 | |
| CPPELGITQPDQDLG | 46 | Q8N2Y8 | |
| GPPAATQPEQVGELC | 236 | Q8NBV8 | |
| EASFQPPPGVNICDV | 86 | Q16563 | |
| LSIEGCQPAIPENPP | 136 | P49848 | |
| AVQCDVGDLQPPPAK | 341 | Q8N1G1 | |
| GELPAEQAIPVCGSP | 1481 | Q93008 | |
| EQAIPVCGSPPTINA | 1486 | Q93008 | |
| LEPSPCPQRCVNTQG | 331 | P07204 | |
| RVQPANNGSPCPELE | 306 | Q9BUD6 | |
| VVDNDVPQPRPGECI | 371 | O95754 | |
| LQPGAICVQEPCQPG | 4841 | A2VEC9 | |
| CDINPLDPGECNPLI | 1636 | O95425 | |
| EPCDNTPIIDNIAPV | 391 | O60282 | |
| TLEGNLVCLQPAPGP | 191 | Q8IYG6 | |
| CQDALNILPVPGPTS | 216 | Q3BBV2 | |
| CQDALNILPVPGPTS | 251 | P0DPF3 | |
| CQDALNILPVPGPTS | 251 | Q6P3W6 | |
| CQDALNILPVPGPTS | 251 | Q86T75 | |
| CQDALNILPVPGPTS | 251 | Q5TAG4 | |
| ECQDALNILPVPGPT | 521 | Q5TAG4 | |
| PAVQSFPLVPCDTDQ | 131 | Q14596 | |
| EACGPPEVSRPNFQV | 66 | Q5JWF2 | |
| VDPAQGVLVAPEPAC | 161 | P58107 | |
| PLNAIEPCVICQGRP | 431 | Q00987 | |
| LPPAVSQVAGAPSQC | 206 | Q8IVL1 | |
| DDVCGLLPFLNPEVP | 636 | Q96CC6 | |
| FNPLSPPDDCALGQT | 731 | Q96PQ0 | |
| PNILIPGTLESGCPQ | 146 | Q9Y336 | |
| SCALNPEEVLEQPQP | 1171 | Q9ULL8 | |
| SVQLQEACFPPGPIR | 206 | Q9H0F6 | |
| SPLCQGSPDPLDLIQ | 831 | Q9UKZ4 | |
| QPCQDPRLIPGAGAT | 401 | A6NM43 | |
| GACLQPEVPLSPAEQ | 346 | Q2NL68 | |
| TPNPSLLAAEDQVPC | 621 | Q9Y253 | |
| ALEPPGPPNAIECVD | 496 | Q6UXD5 | |
| GLPPCAPDLQQEAEQ | 46 | Q15477 | |
| ALDPNIATLGEIPQP | 36 | Q8WXA9 | |
| QIPCPLPVLDHSVGN | 246 | Q969I6 | |
| PPSALNPCEGDFRLQ | 121 | Q68BL8 | |
| TVQPGCSLPSNPEAI | 236 | A4QPH2 | |
| VPVECPQPEEIPNGI | 2436 | Q4LDE5 | |
| APPEPAVGCSLLQQK | 261 | Q9NZP6 | |
| PALEPQPQDPASSVC | 46 | Q9Y2L1 | |
| ESCQURLPPAAUQIS | 341 | P49908 | |
| DLNSVNCDELGPLPP | 296 | Q9HCE7 | |
| QIDSRVCIGAPAPAP | 191 | Q6ZMH5 | |
| PPRQACSSLGPVLNE | 811 | Q7Z6J0 | |
| ERALNCVTQPNPSPG | 811 | P36956 | |
| PEEQLVCVPPQEAFP | 946 | Q9UK61 | |
| ELPPNGPFCLLQEDV | 156 | Q8IZF2 | |
| GLDLAAVTCPPPQLA | 121 | Q6ZS10 | |
| TQLAQPLGPPCQDTG | 251 | Q6ZRI6 | |
| PASQPCSEPVRPAQE | 421 | Q6ZRI6 | |
| PQPESPEAANCIRIG | 286 | Q01973 | |
| LEDAPLLPGNSCPNE | 251 | Q5VZI3 | |
| EVLGNQPAPTCAEPP | 26 | Q8IZ63 | |
| PEAEPGSCLANISQP | 536 | Q2L4Q9 | |
| GEGQCPSLEPQEAVP | 1301 | O15417 | |
| IT IN EXCELL, N | 26 | Q8WZ42 | |
| GQVPDLPSCLPLTDN | 336 | Q8IWX7 | |
| TEEGPLCAQPECPRL | 181 | Q2TAL6 | |
| LLAQTCSQIGKPDPP | 91 | Q9H7S9 | |
| EGVPEPNPELQFICA | 281 | Q96SZ4 | |
| TFNDLVKPVCLPNPG | 356 | O15393 | |
| VSGCEAQAQRLPPTP | 171 | Q7Z2Z1 | |
| ACQEPGGLVVPPTDA | 1236 | P04275 | |
| NVSCPQLEVPVCPSG | 2546 | P04275 | |
| VCPGNAVEPLPSNSE | 1441 | O75970 | |
| PLEVDVNCLPEPNGV | 176 | Q9H2W2 | |
| DGIQKSPCSEPQEPL | 2166 | O60673 | |
| QTPPDLPAQAAPDLC | 851 | Q8WYR1 | |
| QAPDNSLSTVPPGCI | 686 | Q9NXZ1 | |
| GFQAPLSVDPATCPI | 1416 | Q8NI35 | |
| LSVDPATCPIVPGQE | 1421 | Q8NI35 | |
| PQGLLPCQPQEHAVS | 741 | P42226 | |
| QLCQDPAPSLLGPAT | 201 | Q6ZTI6 | |
| SQEDFCPPAPNPELV | 646 | Q6ZQQ2 | |
| CVLFADAPEPGQALP | 631 | Q9C0C2 | |
| SPAPPQLCVVEAPSE | 416 | Q92800 | |
| HLPEPGCQQTVPLSV | 261 | Q2M296 | |
| FNLSCQAQGPPEPVD | 156 | P30530 | |
| SQAPGALQECPPTLA | 576 | P78364 | |
| PQLEPQPECQGPVEA | 306 | Q6ZSY5 | |
| LIPVAAAQEPPGAAC | 26 | P53801 | |
| QPIGPQSTFCEVPLL | 631 | O15040 | |
| PSVPPNGDQGVLSIC | 346 | O75678 | |
| SIPPNGDQGVLSICP | 286 | O75679 | |
| IANPIPNFQCGTLPE | 416 | Q9P283 | |
| LPPQQLGAVFDKCPE | 1056 | Q92797 | |
| PGLPCLNFEAVLSPD | 31 | Q9HC78 | |
| SDLCQPPAQGFVQRP | 51 | A8K0R7 | |
| QAEGDSRPPQDVCLP | 1681 | Q96JG9 | |
| LRPIFSPCLPNEGTN | 441 | Q8N9V2 | |
| PSIPAPAECLPDVQA | 291 | Q96NZ8 | |
| PCQSPLDDPLRKGAN | 286 | Q86TV6 | |
| GSSVNLSPPLEQCVP | 201 | P00734 | |
| LSPPLEQCVPDRGQQ | 206 | P00734 | |
| QTIQDEEGPLCCPHP | 191 | Q9BQ83 | |
| APALGPGQISVSCPE | 1006 | Q5SXM2 | |
| AVSAQPPLPDQCPAL | 51 | Q13641 | |
| AFPLTCAQESVPLGP | 881 | Q9H7P9 | |
| SRDVQGPDPVCSQPI | 1061 | Q9H7P9 | |
| LGPQPPCTEVEDAQF | 271 | Q8WU66 | |
| IRFPQSGAPDPNCVT | 1161 | Q00341 | |
| LNLTVADLPPGAPQC | 486 | Q86VR7 | |
| TDLQRDPPAQCSAGP | 11 | Q9Y2X8 | |
| QPPSFPGAAEERACQ | 531 | Q12789 | |
| LADITLDPPPNCSAG | 56 | P51965 | |
| PPSSSAECNGLQPLV | 301 | Q9Y6X0 | |
| CLEAQGGPSSPVQLP | 206 | Q9H4Z2 | |
| VLCNVACPPPPVEGQ | 936 | Q69YN4 | |
| PPLEPAEAQCLTAEV | 216 | P53814 | |
| FQLSCEAVGPPEPVT | 156 | Q06418 | |
| PQPTDNGFTPKCEIV | 151 | Q9H1B5 | |
| DLNLCTPQPAPLGTD | 81 | Q8IZ20 | |
| QCAAQDGLAPPRSPL | 46 | Q6SJ96 | |
| ASVVNPTPLLPAACG | 66 | A6NJT0 | |
| VPTCLNPDLEGQPLR | 1956 | Q9P2D8 | |
| RPPPQAEAAEVTCPQ | 416 | Q5EBL2 | |
| APQSPCQELAVVPDS | 66 | A6NN73 | |
| PGESVTLPCNALAIP | 591 | Q9NR99 | |
| VEPAIQELFSCPTPG | 21 | Q9UL68 | |
| QVRTVCEPGCPPAEQ | 391 | Q01538 | |
| GVPISPNPANICVAC | 21 | Q96D46 |